Particle.news

Download on the App Store

Framingham Study Links Blood Lipid Subtypes to Alzheimer's Risk

Results highlight unanticipated roles for small dense LDL, low HDL, ApoB48 in forecasting Alzheimer's risk.

Of a total of 822 participants, 128 developed incident Alzheimer’s disease. Credit: Neuroscience News

Overview

  • UT Health San Antonio researchers analyzed lipoprotein profiles of 822 dementia-free participants aged 60 and older from the Framingham Heart Study between 1985 and 2020.
  • Each standard deviation increase in small dense LDL cholesterol corresponded to a 21% greater likelihood of developing Alzheimer's disease.
  • Participants in the lowest HDL cholesterol quartile were 44% less likely to develop Alzheimer's compared to those with higher HDL levels.
  • Elevated ApoB48 concentrations were associated with a 22% reduction in Alzheimer's incidence, suggesting protective lipid transport mechanisms.
  • Findings point to blood-based lipid profiling as a tool for early risk stratification and reinforce that managing cardiovascular health may lower dementia rates.